Experience with and attitude toward clozapine use among patients receiving clozapine on long term and their caregivers
- PMID: 38249152
- PMCID: PMC10795661
- DOI: 10.4103/indianjpsychiatry.indianjpsychiatry_585_23
Experience with and attitude toward clozapine use among patients receiving clozapine on long term and their caregivers
Abstract
Background: Despite clozapine being the gold standard for treating patients suffering from treatment-resistant schizophrenia, the experience and attitude of patients receiving clozapine for a long duration and their caregivers have not been evaluated, especially in India and other low-middle-income countries. Also, no standardized scale has been validated for such assessment.
Objective: This study aimed to evaluate the perception regarding clozapine among patients and their caregivers. We also attempted to evaluate the factor structure of the scale for such assessment.
Methods: A total of 172 consenting patients who have been receiving clozapine for ≥1 year and their caregivers were evaluated on self-designed questionnaires (patient and caregiver versions containing 44 and 47 items, respectively) to assess various aspects of their experiences about clozapine use.
Results: A majority (70-80%) of patients and caregivers reported improvement in psychotic symptoms, mood symptoms, and overall functioning with starting of clozapine. However, about 40% of the patients reported cognitive side effects, and 20-25% reported disabling side effects like lethargy, forgetfulness and decreased attention, and distress related to blood testing after starting of clozapine. Factor analysis of the questionnaires yielded five- and seven-factor models for the experience and attitude of the patients and the caregivers, respectively. The positive experiences were associated clinical and functional improvement, lower disability, and improvement in functioning as well as the self-reported perceived improvement by the patient and caregiver.
Conclusion: This study suggests that patients tend to have an overall positive experience and attitude about using clozapine. The caregivers also report the beneficial effect on the caregiving. A good level of agreement was seen between the experience of patients, caregivers, and clinician-rated improvement in the psychopathology and functioning.
Keywords: Attitude; caregivers; clozapine; experience; patients.
Copyright: © 2023 Indian Journal of Psychiatry.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
Attitude towards and experience with clozapine of patients and their caregivers after three months of starting of clozapine.Nord J Psychiatry. 2021 Jul;75(5):336-343. doi: 10.1080/08039488.2020.1857832. Epub 2020 Dec 29. Nord J Psychiatry. 2021. PMID: 33372832
-
Patient and caregivers perspective about clozapine: A systematic review.Schizophr Res. 2024 Jun;268:223-232. doi: 10.1016/j.schres.2023.06.005. Epub 2023 Jun 27. Schizophr Res. 2024. PMID: 37385885
-
[Caregiver burden in relatives of persons with schizophrenia: an overview of measure instruments].Encephale. 2003 Mar-Apr;29(2):137-47. Encephale. 2003. PMID: 14567165 Review. French.
-
Effect of clozapine on psychological outcomes of caregivers of patients with treatment resistant schizophrenia.Nord J Psychiatry. 2021 Feb;75(2):118-123. doi: 10.1080/08039488.2020.1804617. Epub 2020 Aug 21. Nord J Psychiatry. 2021. PMID: 32820680
-
[Antipsychotics in bipolar disorders].Encephale. 2004 Sep-Oct;30(5):417-24. doi: 10.1016/s0013-7006(04)95456-5. Encephale. 2004. PMID: 15627046 Review. French.
Cited by
-
Pharmacovigilance in Action: Utilizing VigiBase Data to Improve Clozapine Safety.Patient Prefer Adherence. 2024 Nov 12;18:2261-2280. doi: 10.2147/PPA.S495254. eCollection 2024. Patient Prefer Adherence. 2024. PMID: 39553897 Free PMC article. Review.
-
Clozapine Efficacy and Adverse Drug Reactions Among a Nationwide Study of 1021 Australians Prescribed Clozapine: The ClozaGene Study.Schizophr Bull. 2025 Mar 14;51(2):458-469. doi: 10.1093/schbul/sbae065. Schizophr Bull. 2025. PMID: 38713070 Free PMC article.
-
What is the current scope of research assessing patients' and clinicians' perspectives on clozapine treatment? A comprehensive scoping review.BMJ Open. 2025 Jan 15;15(1):e085956. doi: 10.1136/bmjopen-2024-085956. BMJ Open. 2025. PMID: 39819922 Free PMC article.
-
Determinants of patient satisfaction in clozapine users: results from the Clozapine International Consortium (CLOZIN).Schizophrenia (Heidelb). 2025 Feb 23;11(1):28. doi: 10.1038/s41537-025-00570-9. Schizophrenia (Heidelb). 2025. PMID: 39988615 Free PMC article.
References
-
- World Health Organization Schizophrenia. [Last accessed on 2023 Feb 28];2022 Available from: https://www.who.int/news-room/fact-sheets/detail/schizophrenia .
-
- Taylor DM. Clozapine for treatment-resistant schizophrenia: Still the gold standard? CNS Drugs. 2017;31:177–80. - PubMed
-
- Grover S, Balachander S, Chakarabarti S, Avasthi A. Prescription practices and attitude of psychiatrists towards clozapine: A survey of psychiatrists from India. Asian J Psychiatr. 2015;18:57–65. - PubMed
-
- Grover S, Hazari N, Chakrabarti S, Avasthi A. Delay in initiation of clozapine: A retrospective study from a tertiary care hospital in North India. Psychiatry Res. 2015;226:181–5. - PubMed
LinkOut - more resources
Full Text Sources